It is expect­ed that the Med­i­cines and Health­care prod­ucts Reg­u­la­to­ry Agency (MHRA) will con­firm mid-2024 as the new dead­line for the stand­still peri­od dur­ing which CE-marked devices may access the UK mar­ket and thus com­pul­so­ry UKCA mark­ing would also be held up by a year.

In Octo­ber the MHRA clar­i­fied in an open let­ter its plan to extend the stand­still peri­od to 30 June 2024 to give the reg­u­la­tor ade­quate time to ful­ly devel­op the new leg­is­la­tion and safe­guard sup­port sys­tem readiness. 

Source: Medtech Insight (an Infor­ma product)

Accom­pa­ny­ing this sub­ject we rec­om­mend the fol­low­ing con­tent on our website